Aspen Pharmacare said it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, ...

Apple's strong Services growth, Eli Lilly's GLP-1 momentum, and Visa's digital expansion headline today's top stock reports.

Explore Eli Lilly’s role in Healthcare Stocks, S&P 500 companies, and its impact on market trends and the S&P 500 index.

AstraZeneca AZN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States.

A few years ago, if you'd told me that a simple tablet could help people lose more than 10 per cent of their body weight, I'd ...

Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s ...

Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts ...

Fundamentally, Eli Lilly represents a juggernaut in medical innovations. Recently, the company has taken a leadership role in ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Cheryl Fergison has revealed she's lost three stone on weight-loss injection Mounjaro - but says the so-called 'wonder drug' ...

A woman has warned of the 'side effect' that took her by surprise after using a popular weight drug. Weight loss jabs like Mounjaro are increasing in popularity in the US and around the world.